Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Clinical trial NCT05060003 · TERMINATED
Trial details
- NCT number
- NCT05060003
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2023-11-27
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.